Literature DB >> 2844171

Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.

J Striessnig1, H G Knaus, H Glossmann.   

Abstract

This study identifies calcium-antagonist-receptor-carrying polypeptides of calcium channels in guinea-pig hippocampus membranes. The arylazide ligands (-)-[3H]azidopine and [N-methyl-3H]LU49888 [(-)-5-[(3-azidophenethyl) [N-methyl-3H]methylamino]-2-(3,4,5-trimethoxyphenyl-2- isopropylvaleronitrile] were used to selectively label 1,4-dihydropyridine and phenylalkylamine receptors respectively. In the absence of u.v. light, both ligands reversibly bound to a single class of high-affinity receptors with a calcium-channel-typical pharmacological profile. [N-methyl-3H]LU49888 bound to the extent of 849 +/- 188 fmol/mg of protein (mean +/- S.D., n = 3) with a dissociation constant (Kd) of 1.4 +/- 0.3 nM. Under identical assay conditions (-)-[3H]azidopine labelled to the extent of 562 +/- 132 fmol/mg of protein with a Kd of 0.096 +/- 0.024 nM. After u.v. irradiation of the [N-methyl-3H]LU49888- and (-)-[3H]azidopine-labelled membranes, both photo-affinity probes were found to be incorporated specifically into a 190-195 kDa band as shown by SDS/polyacrylamide-gel electrophoresis (SDS/PAGE). Photoincorporation occurred with a protection profile identical with that produced by reversible binding-inhibition. [N-methyl-3H]LU49888, but not (-)-[3H]-azidopine, specifically labelled an additional 265 kDa band. Both photolabelled bands had an identical electrophoretic mobility on SDS/PAGE, irrespective of pretreatment either with 10 mM-N-ethylmaleimide or 10 mM-dithiothreitol. The electrophoretic properties of the 195 kDa polypeptide and the lability of receptor-incorporated (-)-[3H]azidopine to nucleophilic agents resemble those of the previously described drug-receptor-carrying alpha 1 subunit of the purified skeletal-muscle calcium channel. The data suggest that this polypeptide carries both the high-affinity 1,4-dihydropyridine as well as the phenylalkylamine receptor of neuronal calcium channels in guinea-pig hippocampus and is a component of the L-type calcium channel.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844171      PMCID: PMC1149255          DOI: 10.1042/bj2530039

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Identification of an alpha subunit of dihydropyridine-sensitive brain calcium channels.

Authors:  M Takahashi; W A Catterall
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

2.  Purification of putative Ca2+ channel protein from rabbit skeletal muscle. Determination of the amino-terminal sequence.

Authors:  N Nakayama; T L Kirley; P L Vaghy; E McKenna; A Schwartz
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

3.  Monoclonal antibodies against the 1,4-dihydropyridine receptor associated with voltage-sensitive Ca2+ channels detect similar polypeptides from a variety of tissues and species.

Authors:  R I Norman; A J Burgess; E Allen; T M Harrison
Journal:  FEBS Lett       Date:  1987-02-09       Impact factor: 4.124

4.  Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.

Authors:  V Flockerzi; H J Oeken; F Hofmann; D Pelzer; A Cavalié; W Trautwein
Journal:  Nature       Date:  1986 Sep 4-10       Impact factor: 49.962

5.  Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.

Authors:  M Takahashi; M J Seagar; J F Jones; B F Reber; W A Catterall
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.

Authors:  J P Galizzi; M Borsotto; J Barhanin; M Fosset; M Lazdunski
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

7.  Existence of distinct sodium channel messenger RNAs in rat brain.

Authors:  M Noda; T Ikeda; T Kayano; H Suzuki; H Takeshima; M Kurasaki; H Takahashi; S Numa
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

8.  Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.

Authors:  J Striessnig; H G Knaus; M Grabner; K Moosburger; W Seitz; H Lietz; H Glossmann
Journal:  FEBS Lett       Date:  1987-02-23       Impact factor: 4.124

9.  Monoclonal antibodies that coimmunoprecipitate the 1,4-dihydropyridine and phenylalkylamine receptors and reveal the Ca2+ channel structure.

Authors:  S Vandaele; M Fosset; J P Galizzi; M Lazdunski
Journal:  Biochemistry       Date:  1987-01-13       Impact factor: 3.162

10.  Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.

Authors:  J Striessnig; K Moosburger; A Goll; D R Ferry; H Glossmann
Journal:  Eur J Biochem       Date:  1986-12-15
View more
  4 in total

1.  High affinity interaction of mibefradil with voltage-gated calcium and sodium channels.

Authors:  P Eller; S Berjukov; S Wanner; I Huber; S Hering; H G Knaus; G Toth; S D Kimball; J Striessnig
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 2.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

3.  Purified omega-conotoxin GVIA receptor of rat brain resembles a dihydropyridine-sensitive L-type calcium channel.

Authors:  M W McEnery; A M Snowman; A H Sharp; M E Adams; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166.

Authors:  J Striessnig; E Meusburger; M Grabner; H G Knaus; H Glossmann; J Kaiser; B Schölkens; R Becker; W Linz; R Henning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-03       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.